{"transactions":[{"id":1672787,"issuer":{"id":6203,"kind":"organization","name":"Protara Therapeutics, Inc."},"owners":[{"id":94982,"kind":"person","name":"Bandari Jathin","position":1,"cik":"0001903622","reported_name":"Bandari Jathin","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2024-01-23T21:05:30.000Z","date":"2024-01-19","kind":"grant","planned":false,"acquired":true,"shares":137000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"25% of the shares vest on the one year anniversary of January 19, 2024 and 1/48th of the shares vest monthly thereafter over the next three years, subject to the Reporting Person's continuous service with the Issuer as of each such date."}],"balance_after":137000,"derivative":{"exercise_price":1.91,"expiration_date":"2034-01-18","underlying":"Common Stock","underlying_shares":137000},"source":{"system":"sec-edgar","filing":"0001213900-24-005726","document":"marketforms-64335.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1359931/000121390024005726/marketforms-64335.xml","form_type":"4"}},{"id":1672786,"issuer":{"id":6203,"kind":"organization","name":"Protara Therapeutics, Inc."},"owners":[{"id":94982,"kind":"person","name":"Bandari Jathin","position":1,"cik":"0001903622","reported_name":"Bandari Jathin","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2024-01-23T21:05:30.000Z","date":"2024-01-19","kind":"tax_withholding","planned":false,"acquired":false,"shares":2879,"price":1.91,"value":5498.89,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F3","text":"Represents shares withheld by the Issuer to satisfy income tax obligations associated with the vesting of a Restricted Stock Unit Award granted to the Reporting Person on January 19, 2023."}],"balance_after":56704,"source":{"system":"sec-edgar","filing":"0001213900-24-005726","document":"marketforms-64335.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1359931/000121390024005726/marketforms-64335.xml","form_type":"4"}},{"id":1672785,"issuer":{"id":6203,"kind":"organization","name":"Protara Therapeutics, Inc."},"owners":[{"id":94982,"kind":"person","name":"Bandari Jathin","position":1,"cik":"0001903622","reported_name":"Bandari Jathin","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2024-01-23T21:05:30.000Z","date":"2024-01-19","kind":"grant","planned":false,"acquired":true,"shares":23000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The shares being reported are being issued pursuant to restricted stock unit awards (RSUs), each of which represents a contingent right to receive one share of Issuer's common stock. The RSUs vest in equal one-third installments on the first, second and third anniversaries of January 19, 2024."}],"balance_after":59583,"source":{"system":"sec-edgar","filing":"0001213900-24-005726","document":"marketforms-64335.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1359931/000121390024005726/marketforms-64335.xml","form_type":"4"}},{"id":1679832,"issuer":{"id":6203,"kind":"organization","name":"Protara Therapeutics, Inc."},"owners":[{"id":94982,"kind":"person","name":"Bandari Jathin","position":1,"cik":"0001903622","reported_name":"Bandari Jathin","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2024-01-12T21:05:31.000Z","date":"2024-01-10","kind":"tax_withholding","planned":false,"acquired":false,"shares":1877,"price":2.39,"value":4486.03,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares withheld by the Issuer to satisfy income tax obligations associated with the vesting of a Restricted Stock Unit Award granted to the Reporting Person on January 10, 2022."}],"balance_after":36583,"source":{"system":"sec-edgar","filing":"0001213900-24-003334","document":"marketforms-64050.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1359931/000121390024003334/marketforms-64050.xml","form_type":"4"}},{"id":1835414,"issuer":{"id":6203,"kind":"organization","name":"Protara Therapeutics, Inc."},"owners":[{"id":94982,"kind":"person","name":"Bandari Jathin","position":1,"cik":"0001903622","reported_name":"Bandari Jathin","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2023-07-05T20:05:35.000Z","date":"2023-07-03","kind":"tax_withholding","planned":false,"acquired":false,"shares":682,"price":2.46,"value":1677.72,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares withheld by the Issuer to satisfy income tax obligations associated with the vesting of a Restricted Stock Unit Award granted to the Reporting Person on July 1, 2020."}],"balance_after":38460,"source":{"system":"sec-edgar","filing":"0001213900-23-054759","document":"marketforms-61989.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1359931/000121390023054759/marketforms-61989.xml","form_type":"4"}},{"id":2049475,"issuer":{"id":6203,"kind":"organization","name":"Protara Therapeutics, Inc."},"owners":[{"id":94982,"kind":"person","name":"Bandari Jathin","position":1,"cik":"0001903622","reported_name":"Bandari Jathin","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2023-01-20T21:00:09.000Z","date":"2023-01-19","kind":"grant","acquired":true,"shares":124400,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"25% of the shares vest on the one year anniversary of January 19, 2023 and 1/48th of the shares vest monthly thereafter over the next three years, subject to the Reporting Person's continuous service with the Issuer as of each such date."}],"balance_after":124400,"derivative":{"exercise_price":3.02,"expiration_date":"2033-01-18","underlying":"Common Stock","underlying_shares":124400},"source":{"system":"sec-edgar","filing":"0001213900-23-004079","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1359931/000121390023004079/ownership.xml","form_type":"4"}},{"id":2049474,"issuer":{"id":6203,"kind":"organization","name":"Protara Therapeutics, Inc."},"owners":[{"id":94982,"kind":"person","name":"Bandari Jathin","position":1,"cik":"0001903622","reported_name":"Bandari Jathin","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2023-01-20T21:00:09.000Z","date":"2023-01-19","kind":"grant","acquired":true,"shares":20700,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The shares being reported are being issued pursuant to restricted stock unit awards (RSUs), each of which represents a contingent right to receive one share of Issuer's common stock. The RSUs vest in equal one-third installments on the first, second and third anniversaries of January 19, 2023."}],"balance_after":39142,"source":{"system":"sec-edgar","filing":"0001213900-23-004079","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1359931/000121390023004079/ownership.xml","form_type":"4"}},{"id":2056338,"issuer":{"id":6203,"kind":"organization","name":"Protara Therapeutics, Inc."},"owners":[{"id":94982,"kind":"person","name":"Bandari Jathin","position":1,"cik":"0001903622","reported_name":"Bandari Jathin","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2023-01-11T21:02:33.000Z","date":"2023-01-10","kind":"tax_withholding","acquired":false,"shares":1876,"price":3,"value":5628.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares withheld by the Issuer to satisfy income tax obligations associated with the vesting of a Restricted Stock Unit Award granted to the Reporting Person on January 10, 2022."}],"balance_after":18442,"source":{"system":"sec-edgar","filing":"0001213900-23-002260","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1359931/000121390023002260/ownership.xml","form_type":"4"}},{"id":2214098,"issuer":{"id":6203,"kind":"organization","name":"Protara Therapeutics, Inc."},"owners":[{"id":94982,"kind":"person","name":"Bandari Jathin","position":1,"cik":"0001903622","reported_name":"Bandari Jathin","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2022-07-05T21:00:29.000Z","date":"2022-07-01","kind":"tax_withholding","acquired":false,"shares":682,"price":3.22,"value":2196.04,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares withheld by the Issuer to satisfy income tax obligations associated with the vesting of a Restricted Stock Unit Award granted to the Reporting Person on July 1, 2020."}],"balance_after":20318,"source":{"system":"sec-edgar","filing":"0001213900-22-037267","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1359931/000121390022037267/ownership.xml","form_type":"4"}},{"id":2436557,"issuer":{"id":6203,"kind":"organization","name":"Protara Therapeutics, Inc."},"owners":[{"id":94982,"kind":"person","name":"Bandari Jathin","position":1,"cik":"0001903622","reported_name":"Bandari Jathin","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2022-01-12T22:16:38.000Z","date":"2022-01-10","kind":"grant","acquired":true,"shares":81000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"25% of the shares vest on the one year anniversary of January 10, 2022 and 1/48th of the shares vest monthly thereafter over the next three years, subject to the Reporting Person's continuous service with the Issuer as of each such date."}],"balance_after":81000,"derivative":{"exercise_price":6.27,"expiration_date":"2032-01-09","underlying":"Common Stock","underlying_shares":81000},"source":{"system":"sec-edgar","filing":"0001209191-22-003084","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1359931/000120919122003084/doc4.xml","form_type":"4"}},{"id":2436556,"issuer":{"id":6203,"kind":"organization","name":"Protara Therapeutics, Inc."},"owners":[{"id":94982,"kind":"person","name":"Bandari Jathin","position":1,"cik":"0001903622","reported_name":"Bandari Jathin","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2022-01-12T22:16:38.000Z","date":"2022-01-10","kind":"grant","acquired":true,"shares":13500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The shares being reported are being issued pursuant to restricted stock unit awards (RSUs), each of which represents a contingent right to receive one share of Issuer's common stock.  The RSUs vest in equal one-third installments on the first, second and third anniversaries of January 10, 2022."}],"balance_after":13500,"source":{"system":"sec-edgar","filing":"0001209191-22-003084","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1359931/000120919122003084/doc4.xml","form_type":"4"}}]}